knowledge -WSS

knowledge

author：explore 2025-09-14 08:28:57 - browse：215

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： 340B reform proposal comes out of Senate working group

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Cano Health’s bankruptcy is a warning for Medicare Advantage

Problems with a popular proposal to regulate AI in health care

Texas Medical Board asked to define abortion emergency exception

Goldman Sachs launches $650M fund for life science investments

Adopting new red light myopia treatments may be short

explore

knowledge

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

explore

Dobbs anniversary: the lost opportunity of abortion as health care

U.K. sequencing study surfaces new findings about tumor DNA

Medicare details structure of new drug price negotiation program

Adopting new red light myopia treatments may be short

Psychedelics group wrestles with new pharma identity

White House finalizes ITC's import ban of latest Apple Watches

What does generative AI mean for health care? We asked experts

White House finalizes ITC's import ban of latest Apple Watches

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What’s missing from the debate over nursing home staff minimums

focus

Ahead of JPM, here's who's profiting most in health care

Top private equity targets in 2023: cardiology, clinical trials, lasers

J&J to buy cancer drug developer Ambrx Biopharma

Federal weight loss drug coverage is 30 years out of date

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

AI gets buy

Wikipedia

focus

knowledge

hotspot